1.Profiling the dynamic changes of PBMC immune-related indicators in patients with lung cancer after chemotherapy cycles
YOU DUO ; 新乡医学院第一附属医院肿瘤二科 ; CHEN YANAN ; YANG RU ; XU ZHISHAN ; LU PING ; ZHONG GENSHEN
Chinese Journal of Clinical Oncology 2017;44(22):1135-1140
Objective:To explore the optimal time point for combining chemotherapy and immunotherapy and provide an experimen-tal basis for immunotherapy intervention in clinical. Methods:Twenty-three lung cancer patients who completed five chemotherapy cycles between November 2015 and December 2016 in the First Affiliated Hospital of Xinxiang Medical University were enrolled in this study. Numbers of T lymphocyte subsets, B lymphocytes, and NK lymphocytes in peripheral blood were counted. Expression levels of T lymphocyte co-suppression molecule and cytokines in the peripheral blood mononuclear cell were detected using flow cytometry to analyze the dynamic changes of such indicators from one cycle to five cycles of chemotherapy. Results:Significant decreases in the lev-els of CD8+T lymphocytes, CD19+B lymphocytes, and CD16+CD56+NK cells and an increase in CD4+T lymphocytes were observed in the course of multi-cycle chemotherapy for patients with lung cancer. Differences were statistically significant (P<0.05). The co-suppres-sion molecular expression of PD-1, CTLA-4, and CCR-4 with T lymphocytes was downregulated, and the differences were significant (P<0.05). Conclusion:Profiling the dynamic changes of lymphocyte subsets and the expression of T lymphocyte co-suppression molecule are significant in multiple chemotherapy cycles for patients with lung cancer. In the later stage, the combined application of PD-1, PD-L1, CTLA-4, or CCR-4 antibody may exert good therapeutic effects for patients with a high expression level of related immune check-points.
2.Analysis of Association Between Immune Cells and Breast Cancer Based on Two-sample Mendelian Randomization Method
Yuanhang WANG ; Zhiyuan SONG ; Ping LU ; Min ZHANG
Cancer Research on Prevention and Treatment 2024;51(5):348-352
Objective To explore the causal relationship among 731 types of immune cells and breast cancer.Methods Genome-wide association data for immune cells and breast cancer were used.Mendelian randomization analysis was performed using the inverse variance weighting(IVW)and weighted median(WM)methods,and sensitivity analysis was conducted to assess heterogeneity and pleiotropy.Results A total of 19 immune cell phenotypes were identified to potentially have a causal association with breast cancer,using IVW as the main analysis method(P>0.05)and correcting P values using the false discovery rate method at a significance level of 0.05,excluding reverse causality.Of these,eight and 11 immune phenotypes may increase and decrease the risk of breast cancer,respectively.Conclusion This study explored the causal relationship between immune cells and breast cancer.Results show that certain immune cell phenotypes could serve as predictive markers for the early diagnosis of breast cancer and the development of new immun-otherapeutic strategies.
3.Evaluation value of objective nutritional screening tools for esophageal cancer patients undergoing radio-therapy and chemotherapy
Jingjing WANG ; Weidong WANG ; Mengyu WANG ; Qingqin ZHANG ; Xiao-Hong KANG
The Journal of Practical Medicine 2024;40(14):1957-1962
Objective To investigate the application value of prognostic nutritional index and urea/creatinine ratio in nutritional status assessment for patients with esophageal cancer undergoing radiotherapy and chemotherapy.Methods A total of 138 patients with esophageal cancer who received radiotherapy and chemotherapy were screened.NRS 2002 nutritional screening was used as the standard.Prognostic nutritional index(PNI)and urea/cre-atinine ratio(UCR)were used to evaluate the malnutrition of patients with esophageal cancer.ROC curve was used to evaluate and compare the diagnostic efficacy of different nutritional screening tools.Results The biochemical and hematological indexes of patients with esophageal cancer showed certain characteristics,in which the levels of urea,creatinine,UCR,ALB,PALB,TP,TC,TG,HDL and LDL all fluctuated within the normal range.In terms of nutritional risk screening,the NRS 2002 score identified nutritional risk in 57.97%of patients,while the PNI and UCR predicted nutritional risk in 31.16%and 40.58%of patients,respectively.Consistency test showed that the Kappa value of PNI and NRS 2002 scores was 0.460(P<0.05),and the Kappa value of UCR and NRS 2002 scores was 0.522(P<0.05),indicating that there was a certain correlation between them and NRS 2002 scores in nutri-tional risk screening.Correlation analysis showed that NRS 2002 score was significantly correlated with UCR,ALB,PALB,PBL,Cr,HDL and TP(P<0.05),while PNI was significantly correlated with ALB,PALB,PBL,Cr,HDL,TP and UREA(P<0.05).There were significant correlations between UCR and PALB,UREA and Cr(P<0.05).Logistic univariate regression analysis further confirmed these correlations and revealed that malnutrition was negatively correlated with albumin,prealbumin,total protein,lymphocytes,creatinine and BMI,and positively correlated with urea.However,multivariate regression analysis did not find any statistical difference between these related factors and the two objective evaluation measures.The results of diagnostic efficacy evaluation showed that the area under ROC curve of PNI and UCR evaluation to predict esophageal cancer malnutrition was 0.779 and 0.736,respectively,with statistical significance(P<0.001).Among them,UCR showed higher sensitivity and PNI showed higher specificity,but there was no significant difference in diagnostic value between them.Conclusion PNI and UCR as nutritional assessment tools have certain application value in the nutritional risk screening of patients with esophageal cancer,but their consistency with NRS 2002 score needs to be improved.When assessing the nutritional status of patients,a combination of various indicators and methods should be used to achieve more accurate diagnostic results.
4.Research progress in the treatment of oral squamous cell carcinoma
Jing ZHANG ; Min ZHANG ; Ping LU
Journal of Xinxiang Medical College 2024;41(2):180-186
Oral squamous cell carcinoma(OSCC),the most common type of head and neck tumor,is characterized by insidious onset,susceptibility to metastasis,short 5-year survival,and high mortality rate.Currently,various treatment modalities exist for OSCC;however,they inevitably give rise to issues related to non-specific cell death.Therefore,there is an urgent need to explore alternative therapeutic approaches for OSCC.This article provides a comprehensive overview of the recent advance-ments in OSCC treatment,aiming to offer new avenues for future therapeutic strategies.